{
    "report_title": "Drug, Cosmetic and Toiletry Wholesaling Industry Report",
    "report_date": "2023",
    "key_statistics": {
        "revenue": {
            "revenue_dollars": 16378000000,
            "revenue_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "revenue_cagr_value": 3.1
            },
            "revenue_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "revenue_cagr_value": 2.21
            }
        },
        "profit": {
            "profit_dollars": 101,
            "profit_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "profit_cagr_value": 0.0
            },
            "profit_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "profit_cagr_value": 0.0
            }
        },
        "profit_margins": {
            "profit_margins_percentage": 1.2,
            "profit_margins_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "profit_margins_cagr_value": 0.0
            },
            "profit_margins_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "profit_margins_cagr_value": 0.0
            }
        },
        "industry_value_added": {
            "industry_value_added_dollars": 73105000000,
            "industry_value_added_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "industry_value_added_cagr_value": 0.0
            },
            "industry_value_added_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "industry_value_added_cagr_value": 0.0
            }
        },
        "employees": {
            "employees_count": 331316,
            "employees_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "employees_cagr_value": 0.0
            },
            "employees_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "employees_cagr_value": 0.0
            }
        },
        "wages": {
            "wages_dollars": 53747000000,
            "wages_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "wages_cagr_value": 0.0
            },
            "wages_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "wages_cagr_value": 0.0
            }
        },
        "imports": {
            "imports_dollars": 101,
            "imports_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "imports_cagr_value": 0.0
            },
            "imports_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "imports_cagr_value": 0.0
            }
        },
        "exports": {
            "exports_dollars": 101,
            "exports_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "exports_cagr_value": 0.0
            },
            "exports_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "exports_cagr_value": 0.0
            }
        }
    },
    "executive_summary": "The Drug, Cosmetic and Toiletry Wholesaling industry's success is driven by demand for pharmaceuticals. With brand-name drugs losing patent exclusivity, opportunities arose for generic drugs. Wholesalers adjusted prices and supplies. Revenue will rise a CAGR of 3.1% to $1.4 trillion over 2023. COVID-19 boosted demand as hospitalization rates rose in 2020-2021. In 2023, revenue will increase 2.2%. Consolidation increased, with top 3 wholesalers accounting for over 50.0% of industry.",
    "current_performance": [
        {
            "current_performance_point_title": "The Aging of the Population and Rising Insurance Coverage Propel Growth",
            "current_performance_point_description": "The rapidly aging US population has significantly helped drive revenue. Greater health consciousness and Medicare enrollment for older Americans brought demand for prescriptions and industry products. More Americans had healthcare access with the Affordable Care Act, raising demand for wholesalers' primary markets."
        },
        {
            "current_performance_point_title": "Product Mixes Create New Opportunities for Sales Amidst Rising Prices",
            "current_performance_point_description": "Distributors benefit from rising pharmaceutical consumption and accompanying price surges for in-demand drugs. Drug prices rose for brand-name and generics. Insurance advocates for inexpensive generics. In some cases, generic prices increased as manufacturers withheld supply. Generic use enabled wider profitability."
        },
        {
            "current_performance_point_title": "Wholesalers Respond to Pressures by Consolidating",
            "current_performance_point_description": "The top three wholesalers are vertically integrated, commanding over 50.0% of the market."
        }
    ],
    "future_outlook": [
        {
            "future_outlook_point_title": "Amidst Economic Growth, Retail Market Demand Will Rise",
            "future_outlook_point_description": "As disposable income rises, consumers will rely on prescriptions, OTC medications and increase purchases of non-essentials like cosmetics from retail. The aging population will add to medication expenditure. Pharmacies will turn to wholesalers for brand-name and generic prescriptions."
        },
        {
            "future_outlook_point_title": "Vertically Integrated Operates to Bring Specialty and Biopharmaceutical Drugs to Market",
            "future_outlook_point_description": "Companies like the \"Big Three\" will expand into specialty and biopharmaceutical distribution with higher profit. These high-cost drugs require special handling. As population ages, operators focus on this category for conditions like cholesterol and arthritis. Specialty biologics are less prone to generic competition."
        },
        {
            "future_outlook_point_title": "Growing Competition and Stringent Regulations Will Propel Further Consolidation",
            "future_outlook_point_description": "Retailers may circumvent wholesalers as manufacturers find ways to accommodate regulations. Increasing logistics efficiency enables direct manufacturer-to-consumer sales. New safety regulations will jeopardize operating income, pushing wholesalers to consolidate to maintain bargaining power and service nationwide consumers."
        }
    ],
    "industry_definition": "Drug, cosmetic and toiletry wholesalers primarily distribute pharmaceutical products intended for internal and external consumption, such as tablets, capsules, vials, ointments and powders. The industry includes a range of biological and medical products, in addition to botanical drugs and herbs. The industry does not include businesses that primarily distribute surgical, dental or hospital equipment.",
    "industry_impact": {
        "positive_impact_factors": [
            "Revenue Volatility Level low",
            "Capital Intensity Level low",
            "Barriers To Entry Level high - steady"
        ],
        "negative_impact_factors": [
            "Industry Assistance Level low - steady",
            "Competition Level high - increasing"
        ],
        "mixed_impact_factors": []
    },
    "swot_analysis": {
        "strengths": [
            "High & Steady Barriers to Entry",
            "Low Volatility",
            "Low Imports",
            "High Revenue per Employee",
            "Low Capital Requirements"
        ],
        "weaknesses": [
            "Low & Steady Level of Assistance",
            "High Competition",
            "Low Profit vs. Sector Average",
            "High Customer Class Concentration",
            "High Product/Service Concentration"
        ],
        "opportunities": [
            "High Revenue Growth (2018-2023)",
            "High Revenue Growth (2023-2028)",
            "High Performance Drivers - Research and development expenditure"
        ],
        "threats": [
            "Low Revenue Growth (2005-2023)",
            "Low Outlier Growth - Number of people with private health insurance"
        ]
    },
    "key_trends": [
        "Revenue has grown even as brand-name drugs have lost their patents. This has enabled greater sales of generic drugs.",
        "Consolidation has continued across the industry, as the top three distributors are all vertically integrated companies. This has bolstered profit, despite unfavorable pricing trends.",
        "Pharmaceutical supply chains are highly regulated. In addition to federal regulations, some states have passed laws governing the medical supply chain.",
        "Wholesalers must adhere to a range of regulations governing fraud. The Stark Law prohibits referrals for designated health services reimbursable under Medicare or Medicaid to certain entities.",
        "Brand-name drugs generate the bulk of industry revenue. Without generic equivalents, brand-name products are able to charge higher prices.",
        "The retail channel has a diverse mix of companies. Mail-order companies are the fastest-growing provider of prescriptions to the US-insured population.",
        "The West region is a major location for industry wholesalers. Its importance is underscored by its large share of the domestic population.",
        "Access to key markets and manufacturing infrastructure is key for wholesalers. The Southwest region has both an aging population and significant manufacturing capacity.",
        "Diversified product portfolios are essential to success.",
        "Significant legal barriers limit the success of new entrants.",
        "The \"Big Three\" dominate the industry.",
        "Purchase costs represent the lion's share of industry spending.",
        "Profitability has increased."
    ],
    "market_segmentation": [
        {
            "segment": "Other wholesalers",
            "segment_description": "Downstream wholesalers include smaller wholesalers that operate regionally and those smaller wholesalers sell to hospitals and pharmacies and other retailers. This segment has maintained its position as a purchaser because of its ability to successfully move products further downstream.",
            "segment_percentage": 59
        },
        {
            "segment": "Retailers",
            "segment_description": "Retailers represent a diverse segment including warehouse stores, such as Walmart, Target and Costco. The growth of warehouse stores has threatened sales in the industry because large retailers often have the resources to negotiate, purchase and manage sales directly with manufacturers. The segment also includes retail pharmacies and mail-order pharmacy companies.",
            "segment_percentage": 26.4
        },
        {
            "segment": "Businesses",
            "segment_description": "Healthcare providers include hospitals, who process most prescriptions and offer patient care services, such as the administration of vaccines. Hospitals typically source goods from a single wholesaler rather than negotiating prices and deliveries with multiple providers because it is more cost-effective.",
            "segment_percentage": 13.2
        },
        {
            "segment": "Other",
            "segment_description": "",
            "segment_percentage": 1.4
        }
    ],
    "products_and_services": [
        {
            "product_or_service": "Brand-name prescription drugs",
            "product_description": "This segment includes licensed medicines that require written instructions from a physician or other medical practitioner to a pharmacist before a consumer can purchase them. Brand-name drugs are sold under a specific name or trademark that is protected by a patent. The overall rise in sales of all prescription drugs is attributable to the implementation of Medicare Part D, which adds prescription drugs to Medicare coverage, strong growth in several therapeutic classes and increased use of specialty drugs.",
            "product_percentage": 69.4
        },
        {
            "product_or_service": "Generic prescription drugs",
            "product_description": "This segment includes licensed medicines that require written instructions from a physician or other medical practitioner to a pharmacist before a consumer can purchase them. Generic drugs are created to be the same as already marketed brand-name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. Generic drugs are typically less expensive than their branded equivalents, driving volume growth against branded drugs. Since generic drugs have a lower price point, increasing use of them pressures revenue downward until manufacturers and wholesalers manage to control supply enough to drive prices up. Between eight and 10 prescriptions filled are for generic drugs, which is only anticipated to increase as brand-name drugs continue to lose their patents.",
            "product_percentage": 15.4
        },
        {
            "product_or_service": "Cosmetics, toiletries and other",
            "product_description": "This segment includes: - Cosmetics, such as skin-care creams, lotions, powders, perfumes, lipsticks, nail polish, eye and facial makeup, hair colors and hair sprays and gels. - Toiletries include items used for personal hygiene or grooming, such as toothpaste, shampoo and body soap. Cosmetics and toiletries are more sensitive to fluctuations in economic conditions, so consumer demand changes in line with discretionary consumer spending patterns.",
            "product_percentage": 9.4
        },
        {
            "product_or_service": "Nonprescription pharmaceuticals and nutritional supplements",
            "product_description": "This segment includes OTC medications like cough and flu medicines, as well as health supplements and vitamins. Although OTC medications still represent an ancillary product line for wholesalers, the COVID-19 pandemic led to increased demand as individuals",
            "product_percentage": 5.8
        }
    ],
    "supply_chain": {
        "tier_1_suppliers": [
            "Inorganic Chemical Manufacturing in the US",
            "Organic Chemical Manufacturing in the US",
            "Paper Product Manufacturing in the US"
        ],
        "tier_2_suppliers": [
            "Brand Name Pharmaceutical Manufacturing in the US",
            "Generic Pharmaceutical Manufacturing in the US",
            "Cosmetic & Beauty Products Manufacturing in the US",
            "Soap & Cleaning Compound Manufacturing in the US"
        ],
        "tier_1_buyers": [
            "Health Stores in the US",
            "Warehouse Clubs & Supercenters in the US",
            "Department Stores in the US",
            "Pharmacies & Drug Stores in the US",
            "Beauty, Cosmetics & Fragrance Stores in the US"
        ],
        "tier_2_buyers": [
            "Primary Care Doctors in the US",
            "Specialist Doctors in the US"
        ]
    },
    "demand_determinants": [
        {
            "determinant_title": "Access to key markets and manufacturing infrastructure",
            "determinant_description": "Access to key markets and manufacturing infrastructure is key for wholesalers. The Southwest region has both an aging population and significant manufacturing capacity."
        }
    ],
    "international_trade": {
        "import_level": "Low",
        "import_trend": "Steady",
        "export_level": "Low",
        "export_trend": "Steady",
        "international_trade_points": []
    },
    "business_locations": [
        {
            "location": "West",
            "location_description": "The West region is a major location for industry wholesalers. Its importance is underscored by its large share of the domestic population.",
            "percentage_establishments": 0,
            "percentage_population": 30
        }
    ],
    "regulations_and_policies": {
        "regulations_level": "High",
        "regulations_points": [
            {
                "regulation_title": "Prescription Drugs Marketing Act",
                "regulation_description": "Provisions of the Pdma required that wholesalers implement radio-frequency identification (RFID) technology."
            },
            {
                "regulation_title": "Stark Law",
                "regulation_description": "The Stark Law prohibits people from soliciting, offering, receiving or paying any remuneration for the sale of items or services that are in any way paid for by Medicare, Medicaid or other federal healthcare programs."
            },
            {
                "regulation_title": "Pharmaceutical Supply Chain Regulations",
                "regulation_description": "Some states have passed or proposed laws and regulations that aim to protect the safety of the pharmaceutical supply channel."
            },
            {
                "regulation_title": "Drug Supply Chain Security Act",
                "regulation_description": "The DSCSA mandated that all prescription drugs must be able to be traced throughout their entire supply chain by 2023."
            },
            {
                "regulation_title": "Medicare Prescription Drug Improvement and Modernization Act",
                "regulation_description": "The MMA significantly expanded Medicare coverage for outpatient prescription drugs through the new Medicare Part D program."
            }
        ],
        "regulations_trend": "Increasing"
    },
    "barriers_to_entry": {
        "barriers_level": "High",
        "barriers_trend": "Steady",
        "barriers_points": [
            {
                "barrier_title": "Significant legal barriers limit new entrants",
                "barrier_description": "The rules governing pharmaceutical distribution have tightened at the national and state levels."
            }
        ],
        "factors_increased_barrier": [],
        "factors_decreased_barrier": [
            "Revenue Volatility Level: low"
        ]
    },
    "basis_of_competition": {
        "basis_level": "High",
        "basis_trend": "Increasing",
        "basis_points": [
            {
                "basis_title": "Diversified product portfolios essential",
                "basis_description": "Successful wholesalers are able to offer a one-stop shop for a wide variety of drugs and complimentary products."
            }
        ]
    },
    "market_share_concentration": {
        "concentration_level": "Moderate",
        "concentration_trend": "Increasing",
        "concentration_points": [
            {
                "concentration_title": "Big Three Dominate Pharmaceutical Distribution",
                "concentration_description": "McKesson, AmerisourceBergen and Cardinal Healthcare account for more than 50.0% of industry revenue."
            },
            {
                "concentration_title": "Regulation Has Bolstered Industry Concentration",
                "concentration_description": "New regulations have restricted the activities of smaller distributors, making them acquisition targets for the Big Three."
            }
        ],
        "top_companies": [
            {
                "company_name": "Mckesson Corporation",
                "company_percentage": 18.4
            },
            {
                "company_name": "Amerisourcebergen Corp",
                "company_percentage": 15.1
            },
            {
                "company_name": "Cardinal Health, Inc.",
                "company_percentage": 10.6
            },
            {
                "company_name": "OTHERS",
                "company_percentage": 55.9
            }
        ]
    },
    "cost_structure_breakdown": [
        {
            "cost_type": "Purchases",
            "cost_type_percentage": 88.6
        },
        {
            "cost_type": "Wages",
            "cost_type_percentage": 3.9
        },
        {
            "cost_type": "Profit",
            "cost_type_percentage": 1.2
        },
        {
            "cost_type": "Depreciation",
            "cost_type_percentage": 0.1
        },
        {
            "cost_type": "Marketing",
            "cost_type_percentage": 0.1
        },
        {
            "cost_type": "Rent",
            "cost_type_percentage": 0.1
        },
        {
            "cost_type": "Utilities",
            "cost_type_percentage": 0.1
        },
        {
            "cost_type": "Other",
            "cost_type_percentage": 0.1
        }
    ],
    "cost_factors": [
        {
            "cost_factor_title": "Purchases",
            "cost_factor_description": "Purchases account for 88.6% of industry revenue in 2023. Purchases are the largest cost segment for the industry, which is typical of most wholesalers."
        },
        {
            "cost_factor_title": "Wages Limited by Automation",
            "cost_factor_description": "Wage growth has been limited due to the lower volume of human labor employed for daily tasks, such as storing, sorting and transporting goods."
        },
        {
            "cost_factor_title": "Reimbursement Rates Affect Industry Profitability",
            "cost_factor_description": "Increasing healthcare costs have triggered various legal and regulatory measures to contain them, reducing reimbursement levels."
        },
        {
            "cost_factor_title": "Profit Varies Among Name-Brand and Generic Drugs",
            "cost_factor_description": "Profit generated by brand-name pharmaceuticals is much smaller for wholesalers in comparison with profit on generic and specialty drugs because manufacturers charge wholesalers a much higher price to purchase brand-name drugs."
        }
    ],
    "capital_intensity": {
        "capital_intensity_level": "Low",
        "capital_intensity_points": [
            {
                "capital_intensity_title": "Low Capital Intensity",
                "capital_intensity_description": "While computer systems are designed to monitor inventory levels and track sales, significant labor is required at each step of the wholesale distribution process."
            }
        ],
        "capital_intensity_trend": "Unknown"
    },
    "revenue_volatility": {
        "volatility_level": "Low",
        "volatility_points": [
            {
                "volatility_title": "The Essential Nature of Industry Products Limits Volatility",
                "volatility_description": "Given the essential nature of many pharmaceutical and medicine products supplied by this industry, year-to-year volatility tends to be low."
            },
            {
                "volatility_title": "Changing Policies Shifts Demand",
                "volatility_description": "Revenue performance is also affected by changing drug use and mix patterns, government healthcare policies and pricing pressures."
            },
            {
                "volatility_title": "Distribution Agreements with Retailers Affect Sales",
                "volatility_description": "A portion of sales are made to major pharmaceutical distributors and retail chains. Consequently, sales are affected by fluctuations in buying patterns that result from seasonality, pricing, retail buying decisions and changes in overall demand."
            }
        ],
        "volatility_trend": "Unknown"
    },
    "technological_change": {
        "technological_change_level": "Moderate",
        "technological_change_points": [
            {
                "technological_change_title": "Moderate Technology Change",
                "technological_change_description": "The rate of new patent technologies entering the industry is low, which limits the potential for innovations. A low rate does not mean that innovations cannot occur, just that the likelihood of some innovation materializing as a threat is lower."
            }
        ],
        "technological_change_trend": "Unknown"
    },
    "FAQs": [
        {
            "question": "How do shifts in consumers preferences like increased health consciousness, digitalization and sustainability affect your business performance?",
            "answer": "Demand for industry products is driven by shifts in consumer preferences. Consumer preferences are shifting toward generic drugs as brand-name patents run out, boosting demand for that specific industry product. The COVID-19 pandemic led to an increase in demand during 2020, especially for disinfectant and cleaning products."
        },
        {
            "question": "How have your sales been affected by the growth of online shopping?",
            "answer": "Increased online shopping has led to consumers bypassing the wholesaler as manufacturers increasingly offer their products online. However, due to the consolidated nature of this industry, the Big Three have exclusive contracts with many pharmacies, mitigating the threat of online sales."
        },
        {
            "question": "How does the size of your company impact negotiation?",
            "answer": "The industry is dominated by three large wholesaling corporations. The purchasing power of these three companies allows them to negotiate pricing contracts with wholesalers."
        },
        {
            "question": "How has your company explored growth opportunities via mergers and acquisitions?",
            "answer": "The industry is characterized by a lot of merger and acquisition activity among the top three companies."
        },
        {
            "question": "How has your company been able to implement technology solutions?",
            "answer": "Companies have developed online platforms for ordering and tracking industry products. For example, some wholesalers utilize programs like Opti-pak that allow consumers to customize their supply orders. Companies use RFID to efficiently log products from manufacturers and keep track of what consumers order."
        },
        {
            "question": "How does your company monitor potential future changes to the regulatory environment?",
            "answer": "Healthcare regulation has a huge impact on this industry, impacting both the upstream and downstream markets. Companies work with trade associations and lobbying groups to stay informed on potential industry regulations."
        },
        {
            "question": "How does your company ensure all relevant health and safety requirements are met?",
            "answer": "Companies must meet a range of federal health and safety standards. Companies ensure these requirements are met through extensive research and development and product testing."
        },
        {
            "question": "How has the volatility of input prices affected your purchase costs and selling prices during the past five years?",
            "answer": "The increasing price of pharmaceuticals has benefited companies that were able to pass along price raises to the consumer."
        },
        {
            "question": "What cost saving measures are currently employed by your company, and what measures might be implemented in the future?",
            "answer": "Companies mitigate costs by streamlining distribution channels and negotiating favorable contracts with suppliers."
        },
        {
            "question": "Do you have contacts with key distributors and end users? Are you located close to your target markets and suppliers?",
            "answer": "Access to or contracts with reliable manufacturers and importers enables operators to consistently offer products to customers. The COVID-19 pandemic simultaneously led to a sharp rise in demand, necessitating access to key suppliers, while disrupting global supply chains."
        },
        {
            "question": "What are the most important markets for your company? Which contacts provide the most sales?",
            "answer": "Pharmacies, drugstores, hospitals and other healthcare providers are growing in size. Thus, it is increasingly important to establish contacts within these growth markets in order to generate sales."
        },
        {
            "question": "What is your historical performance in meeting consumer expectations? What is your current reputation and how can you improve it?",
            "answer": "Consumers are increasingly using generic versions of prescription pharmaceuticals, and the aging population is using more specialty drugs. Consequently, wholesalers that distribute these products are better positioned to sell to retailers."
        },
        {
            "question": "When consumption investment from the government is low, what other sources does your company turn to? Do you experience changes in revenue or profit when government consumption and investment are low?",
            "answer": "Government investment in public healthcare programs such as Medicare and Medicaid give money to insurance coverage plans that enable consumers to purchase their medications."
        },
        {
            "question": "How have demographics played a role in your company's performance? How does the aging population benefit your company?",
            "answer": "An aging population increases demand for industry products, including both prescription and nonprescription medications."
        },
        {
            "question": "Is your company sensitive to changes in the level of private insurance coverage? How does your company adapt to changing trends in medical coverage?",
            "answer": "Demand for drugs tends to increase when private health insurance membership rises."
        }
    ]
}